In 2022, over $900 million was poured into the pharmacy startup space in an attempt to turn a profit in an area of health care that makes...
Health, Wellness & Biotech
As the venture market significantly slowed, Tiger Global also quietly decelerated dealmaking in the latter half of 2022.
After a strong start to the year, this week slowed down. No round came close to $200 million, and only three rounds hit the $100 million mark. Health...
In the past few years, investment in psychedelic startups has mostly focused on drug development in anticipation of FDA approval. But Oregon has...
Where is seed funding activity on the rise? Out of numerous potential options, we narrowed our take to four emerging themes: carbon capture, AI...
Health care led the way this week with two huge raises totaling nearly $700 million. However, the second week of 2023 produced a lot of big rounds.
Companies like ShiftKey and Incredible Health are good short-term solutions for a decades-long staffing problem that has turned America’s health care...
North American startup investment fell sharply in the fourth quarter, closing out 2022 with funding far below the prior year’s record-setting levels.
As we head into 2023 with recession fears top of mind, here are a few of Crunchbase News’ top predictions for what the new year has in store, based...
The "omics" — genomics, transcriptomics, metabolomics and proteomics — are booming in biotech, with more big raises expected in 2023.
This year hasn’t exactly been a blockbuster for the IPO markets. Venture funding has tanked and fewer startups have dared to step into the public...
67.1K Followers